Literature DB >> 29766856

Procedural Success of Left Ventricular Lead Placement for Cardiac Resynchronization Therapy: A Meta-Analysis.

James H P Gamble1, Neil Herring2, Matthew Ginks2, Kim Rajappan2, Yaver Bashir2, Timothy R Betts2.   

Abstract

OBJECTIVES: The goal of this study was to assess the contemporary and historical success rates of transvenous left ventricular (LV) lead placement for cardiac resynchronization therapy (CRT), their change over time, and the reasons for failure.
BACKGROUND: In selected patients, CRT improves morbidity and mortality, but the placement of the LV lead can be technically challenging.
METHODS: A literature search was used to identify all studies reporting success rates of LV lead placement for CRT via the coronary sinus (CS) route. A total of 164 studies were identified, and a meta-analysis was performed.
RESULTS: The studies included 29,503 patients: 74% (95% confidence interval [CI]: 72% to 76%) were male; their mean age was 66 years (95% CI: 65 to 67); their mean New York Heart Association functional class was 2.8 (95% CI: 2.7 to 2.9); the mean LV ejection fraction was 26% (95% CI: 25% to 28%); and the mean QRS duration was 155 ms (95% CI: 150 to 160). The overall rate of failure of implantation of an LV lead was 3.6% (95% CI: 3.1 to 4.3). The rate of failure in studies commencing before 2005 was 5.4% (95% CI: 4.4% to 6.5%), and from 2005 onward it was 2.4% (95% CI: 1.9% to 3.1%; p < 0.001). Causes of failure (reported for 39% of failures) also changed over time. Failure to cannulate and navigate the CS decreased from 53% to 30% (p = 0.01), and the absence of any suitable, acceptable vein increased from 39% to 64% (p = 0.007). The proportion of leads in a lateral or posterolateral final position (reported for 26% of leads) increased from 66% to 82% (p = 0.004).
CONCLUSIONS: The reported rate of failure to place an LV lead via the CS has decreased steadily over time. A greater proportion of failures in recent studies are due to coronary venous anatomy that is unsuitable for this technique.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac resynchronization therapy; complications; coronary sinus; left ventricular lead; procedural success

Year:  2015        PMID: 29766856     DOI: 10.1016/j.jacep.2015.08.009

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  14 in total

1.  Leadless Left Bundle Branch Area Pacing in Cardiac Resynchronisation Therapy: Advances, Challenges and Future Directions.

Authors:  Nadeev Wijesuriya; Mark K Elliott; Vishal Mehta; Baldeep S Sidhu; Marina Strocchi; Jonathan M Behar; Steven Niederer; Christopher A Rinaldi
Journal:  Front Physiol       Date:  2022-06-06       Impact factor: 4.755

2.  Short QRS Duration After His-Purkinje Conduction System Pacing Predicts Left Ventricular Complete Reverse Remodeling in Patients With True Left Bundle Branch Block and Heart Failure.

Authors:  Xu-Min Guan; Dan-Na Li; Fu-Lu Zhao; Yan-Ni Zhao; Yi-Heng Yang; Bai-Ling Dai; Shi-Yu Dai; Lian-Jun Gao; Yun-Long Xia; Ying-Xue Dong
Journal:  Front Cardiovasc Med       Date:  2022-05-06

3.  Successful use of venovenous snare to fix the wire in a collateral vein for proper placement of the left ventricular lead during cardiac resynchronization therapy: a case report.

Authors:  Muni Venkatesa Reddy; Saurabh Ajit Deshpande; Shishir Kumar Roul; Ameya Udyavar
Journal:  Eur Heart J Case Rep       Date:  2020-05-26

4.  Lead one ratio in left bundle branch block predicts poor cardiac resynchronization therapy response.

Authors:  Zak Loring; Daniel J Friedman; Kasper Emerek; Claus Graff; Peter L Sørensen; Steen M Hansen; Bjorn Wieslander; Martin Ugander; Peter Søgaard; Brett D Atwater
Journal:  Pacing Clin Electrophysiol       Date:  2020-05-08       Impact factor: 1.976

5.  The use of lubricating solution as a novel method in facilitating left ventricular lead placement: A case series.

Authors:  Pedram Kazemian; Andrew Mathew; Raffaele Corbisiero; Michael Flynn
Journal:  HeartRhythm Case Rep       Date:  2020-03-13

6.  Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: A multicenter international registry of the WiSE-CRT pacing system.

Authors:  Benjamin J Sieniewicz; Timothy R Betts; Simon James; Andrew Turley; Christian Butter; Martin Seifert; Lucas V A Boersma; Sam Riahi; Petr Neuzil; Mauro Biffi; Igor Diemberger; Pasquale Vergara; Martin Arnold; David T Keane; Pascal Defaye; Jean-Claude Deharo; Anthony Chow; Richard Schilling; Jonathan Behar; Christopher A Rinaldi
Journal:  Heart Rhythm       Date:  2020-03-09       Impact factor: 6.343

7.  A right subclavian vein approach for interventricular septum puncture and left ventricular endocardial lead placement in cardiac resynchronization therapy.

Authors:  Rogelio Robledo-Nolasco; Gerardo De León-Larios; Oziel Gutierrez-Villegas; Elias Zavaleta-Muñiz; David Eduardo Bazzini Carranza; Omar Calixto-Vargas
Journal:  HeartRhythm Case Rep       Date:  2019-02-19

8.  His bundle pacing, learning curve, procedure characteristics, safety, and feasibility: Insights from a large international observational study.

Authors:  Daniel Keene; Ahran D Arnold; Marek Jastrzębski; Haran Burri; Steven Zweibel; Eric Crespo; Badrinathan Chandrasekaran; Sukhbinder Bassi; Nader Joghetaei; Matthew Swift; Pawel Moskal; Darrel P Francis; Paul Foley; Matthew J Shun-Shin; Zachary I Whinnett
Journal:  J Cardiovasc Electrophysiol       Date:  2019-08-02

9.  Cardiac resynchronization therapy with intraoperative epicardial mapping via minithoracotomy: 10 years' experience.

Authors:  László Hejjel; Marianna Németh; László Melczer; Attila Kónyi
Journal:  Pacing Clin Electrophysiol       Date:  2020-11-26       Impact factor: 1.976

Review 10.  Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions.

Authors:  Benjamin J Sieniewicz; Justin Gould; Bradley Porter; Baldeep S Sidhu; Thomas Teall; Jessica Webb; Gerarld Carr-White; Christopher A Rinaldi
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.